2026 Annual Meeting | C125 - Neuro-otology
Program Materials Program Evaluations
| 07:00 AM - 07:05 AM CDT | Introduction |
Welcome and Introduction
Kristen K. Steenerson, MD, FAAN |
| 07:05 AM - 07:30 AM CDT | Speaker |
Neuro-otology in the Emergency Department
Daniel R. Gold, DO |
| 07:30 AM - 07:55 AM CDT | Speaker |
Neuro-otology in the General Neurology Clinic
Kevin A. Kerber, MD |
| 07:55 AM - 08:20 AM CDT | Speaker |
Neuro-otology in the Neuro-otology Clinic
Miriam S. Welgampola, MD |
| 08:20 AM - 08:45 AM CDT | Speaker |
Neuro-otology in the Otology Clinic
Kristen K. Steenerson, MD, FAAN |
| 08:45 AM - 09:00 AM CDT | Q&A |
Questions and Answers
Kristen K. Steenerson, MD, FAAN, Daniel R. Gold, DO, Kevin A. Kerber, MD, Miriam S. Welgampola, MD |
| Miriam S. Welgampola, MD | Dr. Welgampola has nothing to disclose. |
| Kristen K. Steenerson, MD, FAAN | Dr. Steenerson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otolith. The institution of Dr. Steenerson has received research support from Wu Tsai Neurosciences Institute, Stanford University. |
| Daniel R. Gold, DO | Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer . Dr. Gold has received publishing royalties from a publication relating to health care. |
| Kevin A. Kerber, MD | Dr. Kerber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Academy of Neurology. The institution of Dr. Kerber has received research support from National Institutes of Health. The institution of Dr. Kerber has received research support from Genentech, Inc . Dr. Kerber has received publishing royalties from a publication relating to health care. |